| ID Source | ID |
|---|---|
| PubMed CID | 193324 |
| CHEMBL ID | 2075012 |
| SCHEMBL ID | 4948189 |
| MeSH ID | M0082164 |
| Synonym |
|---|
| corticosterone sulfate |
| 1105-02-8 |
| [2-[(8s,9s,10r,11s,13s,14s,17s)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hydrogen sulfate |
| bdbm50420242 |
| (11beta)-11-hydroxy-21-(sulfooxy)pregn-4-ene-3,20-dione |
| CHEMBL2075012 , |
| SCHEMBL4948189 |
| corticosterone 21-sulfate potassium |
| 100775-23-3 |
| 11-hydroxy-3,20-dioxopregn-4-en-21-yl hydrogen sulfate |
| DTXSID60911709 |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 1.6000 | 1.1000 | 4.5125 | 9.8000 | AID681147 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID681147 | TP_TRANSPORTER: inhibition of E217betaG uptake in Oatp1-expressing HeLa cells | 1996 | The American journal of physiology, Feb, Volume: 270, Issue:2 Pt 2 | Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.98) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||